Inspire Medical [INSP] vs Establishment Labs [ESTA] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Inspire Medical Systems, Inc. wins in 17 metrics, Establishment Labs Holdings Inc. wins in 2 metrics, with 0 ties. Inspire Medical Systems, Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Inspire Medical Systems, Inc. | Establishment Labs Holdings Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 10.64 | -37.89 | Inspire Medical Systems, Inc. |
| Price-to-Book Ratio | 1.90 | 79.68 | Inspire Medical Systems, Inc. |
| Debt-to-Equity Ratio | 4.12 | 1,123.15 | Inspire Medical Systems, Inc. |
| PEG Ratio | 0.04 | 0.41 | Inspire Medical Systems, Inc. |
| EV/EBITDA | 18.66 | -70.21 | Inspire Medical Systems, Inc. |
| Profit Margin (TTM) | 15.95% | -24.19% | Inspire Medical Systems, Inc. |
| Operating Margin (TTM) | 17.14% | -6.08% | Inspire Medical Systems, Inc. |
| EBITDA Margin (TTM) | 17.14% | N/A | N/A |
| Return on Equity | 19.77% | -133.25% | Inspire Medical Systems, Inc. |
| Return on Assets (TTM) | 3.71% | -6.93% | Inspire Medical Systems, Inc. |
| Free Cash Flow (TTM) | $78.48M | $-57.61M | Inspire Medical Systems, Inc. |
| 1-Year Return | -70.07% | 105.37% | Establishment Labs Holdings Inc. |
| Price-to-Sales Ratio (TTM) | 1.64 | 8.92 | Inspire Medical Systems, Inc. |
| Enterprise Value | $1.21B | $2.07B | Establishment Labs Holdings Inc. |
| EV/Revenue Ratio | 1.33 | 9.79 | Inspire Medical Systems, Inc. |
| Gross Profit Margin (TTM) | 86.59% | 70.46% | Inspire Medical Systems, Inc. |
| Revenue per Share (TTM) | $31 | $7 | Inspire Medical Systems, Inc. |
| Earnings per Share (Diluted) | $4.89 | $-1.72 | Inspire Medical Systems, Inc. |
| Beta (Stock Volatility) | 0.86 | 1.08 | Inspire Medical Systems, Inc. |
| Short % of Float | 14.57% | 22.26% | Inspire Medical Systems, Inc. |
Inspire Medical Systems, Inc. vs Establishment Labs Holdings Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Inspire Medical Systems, Inc. | -0.35% | -4.22% | -26.26% | -38.54% | -69.99% | -56.17% |
| Establishment Labs Holdings Inc. | 2.84% | 1.53% | 3.09% | 1.83% | 6.86% | 5.19% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Inspire Medical Systems, Inc. | -70.07% | -86.64% | -74.92% | 69.02% | 69.02% | 69.02% |
| Establishment Labs Holdings Inc. | 105.37% | 6.40% | -6.53% | 167.87% | 167.87% | 167.87% |
Performance & Financial Health Analysis: Inspire Medical Systems, Inc. vs Establishment Labs Holdings Inc.
| Metric | INSP | ESTA |
|---|---|---|
| Market Information | ||
| Market Cap | $1.62B | $1.91B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 951,377 | 451,437 |
| 90 Day Avg. Volume | 976,586 | 478,309 |
| Last Close | $40.44 | $72.41 |
| 52 Week Range | $38.91 - $147.03 | $33.35 - $83.31 |
| % from 52W High | -72.50% | -13.08% |
| All-Time High | $330.00 (Jul 10, 2023) | $93.80 (Apr 18, 2022) |
| % from All-Time High | -87.75% | -22.80% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.12% | 0.45% |
| Quarterly Earnings Growth | 2.86% | 0.45% |
| Financial Health | ||
| Profit Margin (TTM) | 0.16% | -0.24% |
| Operating Margin (TTM) | 0.17% | -0.06% |
| Return on Equity (TTM) | 0.20% | -1.33% |
| Debt to Equity (MRQ) | 4.12 | 1,123.15 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $27.33 | $0.80 |
| Cash per Share (MRQ) | $10.78 | $2.58 |
| Operating Cash Flow (TTM) | $116.98M | $-50,890,000 |
| Levered Free Cash Flow (TTM) | $54.50M | $-41,574,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Inspire Medical Systems, Inc. vs Establishment Labs Holdings Inc.
| Metric | INSP (Apr 24, 2026) | ESTA (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 10.64 | -37.89 |
| Forward P/E | 20.13 | 316.35 |
| PEG Ratio | 0.04 | 0.41 |
| Price to Sales (TTM) | 1.64 | 8.92 |
| Price to Book (MRQ) | 1.90 | 79.68 |
| Market Capitalization | ||
| Market Capitalization | $1.62B | $1.91B |
| Enterprise Value | $1.21B | $2.07B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.33 | 9.79 |
| Enterprise to EBITDA | 18.66 | -70.21 |
| Risk & Other Metrics | ||
| Beta | 0.86 | 1.08 |
| Book Value per Share (MRQ) | $27.33 | $0.80 |
Financial Statements Comparison: Inspire Medical Systems, Inc. vs Establishment Labs Holdings Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | INSP (2025) | ESTA (2025) |
|---|---|---|
| Revenue/Sales | 911.98M | 211.08M |
| Cost of Goods Sold | 133.23M | 64.77M |
| COGS % of Revenue | 14.6% | 30.7% |
| Gross Profit | 778.76M | 146.31M |
| Gross Margin | 85.4% | 69.3% |
| Research & Development | 103.17M | 20.25M |
| Operating Income (EBIT) | 50.95M | -39.01M |
| Operating Margin | 5.6% | -18.5% |
| EBITDA | 79.79M | -22.29M |
| EBITDA Margin | 8.7% | -10.6% |
| Pre-Tax Income | 65.70M | -58.02M |
| Pre-Tax Income % of Revenue | 7.2% | -27.5% |
| Income Tax | -79.73M | -6.96M |
| Income Tax % of Revenue | -8.7% | -3.3% |
| Net Income (Profit) | 145.42M | -51.06M |
| Profit Margin | 15.9% | -24.2% |
Balance Sheet & Liquidity Metrics
| Metric | INSP (2025) | ESTA (2025) |
|---|---|---|
| Cash & Equivalents | 104.81M | 75.57M |
| Total Current Assets | 583.65M | 249.94M |
| Total Current Assets % of Revenue | 64.0% | 118.4% |
| Total Current Liabilities | 96.06M | 82.14M |
| Total Current Liabilities % of Revenue | 10.5% | 38.9% |
| Long-Term Debt | 30.00M | 250.34M |
| Long-Term Debt % of Revenue | 3.3% | 118.6% |
| Total Shareholders Equity | 781.16M | 23.55M |
| Retained Earnings | -146.49M | -495.76M |
| Retained Earnings % of Revenue | -16.1% | -234.9% |
| Property, Plant & Equipment | 54.21M | 4.34M |
Cash Flow Statement Comparison
| Metric | INSP (2025) | ESTA (2025) |
|---|---|---|
| Operating Cash Flow | 107.85M | -50.78M |
| Operating Cash Flow % of Revenue | 11.8% | -24.1% |
| Capital Expenditures | -38.50M | -6.05M |
| Free Cash Flow | 78.48M | -57.61M |
| FCF Margin | 8.6% | -27.3% |
| Debt Repayment | N/A | -1.02M |
| Common Stock Repurchase | -175.02M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | INSP | ESTA |
|---|---|---|
| Shares Short | 3.20M | 5.22M |
| Short Ratio | 3.37 | 9.90 |
| Short % of Float | 14.57% | 22.26% |
| Shares Outstanding | 28.58M | 29.30M |
| Float Shares | 26.71M | 19.22M |
| % Held by Insiders | 1.17% | 10.16% |
| % Held by Institutions | 121.08% | 102.08% |
| % Held by Public | -22.25% | -12.24% |
Dividend Analysis & Yield Comparison: Inspire Medical Systems, Inc. vs Establishment Labs Holdings Inc.
| Metric | INSP | ESTA |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |